An October 2023 survey, commissioned by Research!America in partnership with the Association for Clinical Research Organizations (ACRO), surveyed more than 2,000 U.S. adults and found that Americans are less […]
More: Americans Decreasingly Willing to Share Health Information, But Place High Value on Clinical TrialsResearch!America recently hosted a conversation about the importance and impact of advocacy with two extraordinary research champions, Dr. Joanne Pike, President and CEO of the Alzheimer’s Association, and Tony Gonzales, […]
More: Alliance Discussion with the Alzheimer’s Association: The Power of Advocacy in Addressing the Dementia Public Health CrisisA diverse and inclusive research environment that engages scientists and community members is key to good science that leads to better health outcomes for all. Gelise Thomas, Assistant Director of […]
More: Alliance Discussion with Gelise Thomas: Diversifying the Research Landscape through Research Equity, Accessibility, Diversity, and Inclusion InitiativesWhere Are They Now? From Research!America Intern to HHS ORISE Fellow, Catching up with Dr. Jessica Scott Research!America relies on interns and fellows, whose skills drive our mission forward. In […]
More: Where Are They Now? From Research!America Intern to HHS ORISE Fellow, Catching up with Dr. Jessica ScottIn a July 27, 2022, alliance discussion, Randall (Randy) Rutta, Chief Executive Officer of the National Health Council (NHC), discussed his work with NHC, the organization’s vision for patient centricity, the […]
More: Alliance Discussion with Randall Rutta: The National Health Council’s Vision for Patient CentricityA recent Research!America blog post discussed the issue of vaccine hesitancy as an obstacle to ensuring that enough U.S. residents receive a COVID-19 vaccine. However, vaccine hesitancy is far from the only barrier to achieving equitable vaccine
More: Barriers to Immunization: Beyond Vaccine HesitancyAs the COVID-19 vaccine rolls out across the U.S., one question on everyone’s mind is, “when do things go back to normal?” The answer depends largely on when most Americans will be vaccinated. And vaccine
More: COVID-19 Vaccine Distribution: Addressing Vaccine HesitancyAs COVID-19 cases continue to surge, the FDA’s authorization of the Pfizer and Moderna vaccines is a critical step towards immobilizing the spread of COVID-19. But ensuring a critical mass of people are vaccinated is essential in
More: Mastering COVID-19 Vaccine MessagingThyroid eye disease is a serious, debilitating, and vision-threatening autoimmune disease where the immune system attacks muscles and other tissue behind and around the eyes, which can result in potentially […]
More: Seeing the Way to Treatment for Eye Disease
